Dong M. Shin, MD, FACP

Dong Moon Shin, MD, FACP, is the Frances Kelly Blomeyer Distinguished Endowed Chair in Cancer Research, Professor of Hematology and Medical Oncology, Professor of Otolaryngology, Professor of Biomedical Engineering, Director of the Head and Neck Cancer SPORE Program and Georgia Cancer Coalition Distinguished Scholar at Winship Cancer Institute of Emory University.

A board certified medical oncologist by the American Board of Internal Medicine, Dr. Shin is sought after for the treatment of head and neck cancer along with mesothelioma, thymoma and thymic carcinoma. Currently he is focusing on treatment and research in head and neck cancer.

Dr. Shin has a highly successful scholar and research track record as a head and neck cancer investigator. He is a well-established, internationally and nationally recognized clinician and  investigator in head and neck cancer research related to biology, biomarkers, chemoprevention, biochemoprevention, new drug discovery by nanotherapeutics, and new molecularly-based and immune-based innovative therapies. He has published more than 350 articles in the professional journals in addition to numerous  books and book chapters related to head and neck cancer and other cancers.

Dr. Shin is a Fellow of the American College of Physicians and a Fellow of the American Association for the Advancement of Science, and has been consecutively recognized as one of America's Top Doctors in Oncology in Castle Connolly Medial Ltd., and Top Doctors in Atlanta Magazinesince since 2005.

He has been  also yearly recognized as the Best Doctors in America since 2003.

Prior to joining Emory, he served as a faculty member in the Department of Head and Neck/Thoracic Medical Oncology at M.D. Anderson Cancer Center, in Houston, and also served as Professor of Oncology and Director of Head and Neck Cancer Program at the University of Pittsburgh.

Dr. Shin graduated from Medical School in Yonsei University College of Medicine in Seoul, Korea in 1975. He completed Internships at Yonsei University Hospital in 1979 and at Cook County Hospital in Chicago in 1983. He also completed his Residency in Internal Medicine  at Cook County Hospital in 1985 and his Fellowship in Medical Oncology  at University of Texas, M.D. Anderson Cancer Center in Houston in 1988.

• American Association of Cancer Research
• American College of Physicians (Fellow)
• American Head and Neck Society
• American Society of Clinical Oncology
• American Association of the Advancement of Science (Fellow)

• Clinical Oncology Career Development Award from American Cancer Society, 1994
• Faculty Scholar Award at the University of Texas M. D. Anderson Cancer Center, 2000
• Best Doctors in America, 2003-Present
• "Top Doctors" in Atlanta Magazine, 2005-Present
• America's Top Doctors in Cancer by Castle Connolly Medical Ltd. 2005-Present
• Georgia Cancer Coalition (GCC) Distinguished Scholar Award, 2005
• America's Top Oncologist in Cancer by Consumer's Research Council of America, 2007
• Cambridge Who's Who Life Time Member, 2007
• Francis Kelly Blomeyer Distinguished Chair in Cancer Research, 2008 to present
• "MilliPub Club" Award from Emory University School of Medicine, 2011, 2015-2019
• Top Doctors featured in U.S. News & World Report, 2012/2013
• Korean Broadcasting System (KBS) Overseas Compatriots Award in Science and Technology, 2015
• Elected Fellow of American Association of the Advancement of Science (FAAAS) in 2016